在患有遗传性瘤综合征的患者中进行向治疗
Arne Jahn1, Christoph Heining2, Stefan Fröhling3
1University Hospital Carl Gustav Carus at TUD Dresden University of Technology and Faculty of Medicine of TUD Dresden University of Technology Institute for Clinical Genetics Fetscherstr. 74 01307 Dresden Germany.
综合性基因组分析有助于通过识别可能的致病性生殖系变异 (PGVs) 来进行先进的癌症治疗. 这些PGV指导有针对性的疗法,遗传咨询和化疗预防策略,以改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子诊断学 分子诊断学
背景情况:
- 由于分子诊断和向治疗,先进的恶性瘤的结果得到了改善.
- 综合性基因组分析需要跨学科的分子瘤板来提供临床建议.
- 可能致病性生殖系变体 (PGVs) 需要为患者和家人提供遗传咨询.
研究的目的:
- 突出将生殖线改变纳入临床决策的整合.
- 强调PGVs在指导向治疗选择中的作用.
- 探索PGV在有针对性的化学预防策略中的潜力.
主要方法:
- 关于分子诊断和向治疗的当前文献的综述.
- 对生殖系变异在癌症治疗中的影响进行分析.
- 讨论分子瘤板在临床决策中的作用.
主要成果:
- 综合性基因组分析识别了PGV,这些PGV可以为治疗决策提供信息.
- 向疗法越来越多地受到生殖线改变的影响.
- PGV为风险评估和有针对性的化学预防提供了机会.
结论:
- 跨学科的合作对于解释基因组数据和实施个性化癌症护理至关重要.
- 鉴定生殖系变异对于优化向治疗和化疗预防至关重要.
- 分子诊断和PGV分析显著提高了晚期恶性瘤的患者管理.
更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
相关概念视频
Targeted Cancer Therapies
There are several types of targeted therapies against...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Tumor Immunotherapy
Treatment Resistant Cancers
Cancer
